Advanced Wound Care begins to stabilize as in-person visits increase and elective procedures rebound.

For Q121, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was up +6.2%, boosted by a strong performance in Biologics, with 3M maintaining the number one position in the AWC space.

Among the many topics covered in detail in our comprehensive Q121 AWC Market Recap* are:

Procedures using surgical matrices continued their recovery, with breast matrices benefiting more from comparison to the early stages of the pandemic that began last year.

Procedures using surgical matrices resumed their return to pre-COVID levels. The US Surgical Matrices market returned to growth according to BioMedGPS’ SmartTRAK Financial Dashboard. AbbVie continued to lead the Surgical Matrices market while Becton Dickinson (BD), although still leading the US Hernia Matrices market, continued to slide as the hernia market lagged the recovery in breast matrices.

Among the many topics covered in detail in our comprehensive Q121 US Surgical Matrices Market Recap* are:

The US market for Hemostats and Sealants resumed its growth in Q121 as procedures climbed back towards normal.

While surgical procedures have not fully regained their pre-COVID levels, the US Hemostats and Sealants market grew in Q121 according to SmartTRAK Financial Dashboard. However, it continued to be a tale of two recoveries. CryoLife* and especially JNJ/Ethicon* posted solid gains for the quarter. However, as elective procedures continue to be behind pre-COVID levels, other manufacturers lagged by comparison.

The Symposium on Advanced Wound Care, SAWC, the official meeting of the Wound Healing Society, was held virtually May 10-14 and SmartTRAK attended.

Following is a sampling of some of the takeaways from the meeting that were gathered and curated by our expert analysts and sent out to subscribers in our Daily Updates.

A year of turbulence as COVID-19 affects the WW Advanced Wound Care market at different times and in a variety of ways throughout the year.

For FY20, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was down -1.9% YoY. Q420 grew +1.0%, reflecting the gradual recovery in the market.

Among the many topics covered in the comprehensive Q420/FY20 Advanced Wound Care Market Recap* are:

Anticipated growth for Q4 was weakened by a resurgence of COVID-19 and was not enough to sustain growth with FY20 ending at -3.3% YoY decline.

For FY20, according SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access (VA) Adjunct Products market was down -3.3% YoY, while Q420 revenue was up  +1.2% YoY.

The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.

Among the many topics covered in the comprehensive Q420/FY20 Infection Prevention: US Vascular Access Adjunct Market* are:

Ragna Ouwerkerk, PR Manager at Mediq, discusses the Company and its recent acquisitions in an interview with SmartTRAK.

Mergers and acquisitions have become an attractive business strategy for companies in the wound care space considering to expand into new markets or territories, reach a competitive edge or obtain new technologies. One company looking to strengthen its leadership position in the European wound care market through acquisitions is  Mediq.

Mediq is a Dutch healthcare company founded in 1899 by ninety-one pharmacists as a type of buying group to check the quality of raw materials and medicines. In 2021, Mediq provides pharmaceuticals and medical devices to patients and healthcare facilities globally. Recently, the Company decided to take a major step forward and has had a flurry of acquisitions in the last few months of which some strengthened the presence of the company in some European countries and another helped to enter the UK market.

SmartTRAK: The Company has recently acquired Medirum AB in Sweden, Puls AS in Norway, H&R Healthcare Ltd in the UK, GD Medical AG in Switzerland and Replant 4 Care in Hungary. Mediq also intends to acquire Eurocept Homecare and Da Vinci Kliniek in the Netherlands. What was your thinking behind those acquisitions?

The recovery in breast and hernia procedure stalled in Q420, with revenue dropping -9.2% YoY, according to BioMedGPS’ SmartTRAK Financial Dashboard. AbbVie* maintained its lead despite the effects of the pandemic, off -8.4% YoY, as its breast matrices continued to lag in the overall recovery. Becton Dickinson* (BD) slid –1.2% YoY as hernia procedures bounced back to normal levels a little faster ...

Among the many topics covered in the comprehensive Q420/FY20 US Surgical Matrices Market Recap* are:

Facing the prevailing headwinds of the pandemic, the MedTech industry presses on with product innovation and plans for the future. SmartTRAK reports daily on the challenges still ahead, covering all aspects of the Wound Care market, including Advanced Wound Care, Conventional Wound Care, Infection Prevention, Biosurgery, Surgical Matrices, EU and ROW Advanced Dressings and EU Negative Pressure Wound Therapy.

The following is just a small sampling of the Wound Care updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, patents, trends, new products, financial data and competitor developments in the global Life Sciences industry.

As part of SmartTRAK's R&D appreciation month, Research & Development professionals can now sign up for a Complimentary Month of Daily Updates delivered straight to your inbox. Just let us show you SmartTRAK and we'll give you a month of Daily Updates for FREE!

Patents:

• Medtronic*
  Medtronic’s US Patent Application “POWERED SURGICAL TACK APPLIER” was published, describing a powered system for surgical tack application for hernia repair. 20210045740

SmartTRAK analyzes how COVID-19 and vaccinations will impact the US Advanced Wound Care Market in 2021.

The impact of COVID-19 on life in the US and its onslaught into the US health care system began in mid-March. CMS and the American College of Surgeons recommended that hospitals, physicians and clinics halt all non-essential medical and surgical procedures, including the treatment of many types of wounds. However, the continual care of a chronic wound is essential for patients to ensure it is on the correct trajectory to heal. Typically, clinicians treat chronic wounds at least once a week to assess the progress of the wound, provide debridement and/or apply CTPs (skin substitutes). The hospital outpatient department (HOPD) wound clinics have been the primary site-of-care to treat these wounds but with the closing of several of these facilities during the initial COVID surge, many patients with chronic wounds were not seen, delayed treatment or began the transfer to the physician office for treatment. In fact, there is some evidence that wounds increased in severity since the start of the pandemic resulting in greater use of higher technology products and unfortunately, an increase in amputations.

The most significant impact on the market occurred in April/May 2020 when several states went into lock down and most, if not all, elective procedures were cancelled. SmartTRAK analyzed the Advanced Wound Care market back in April with the assumption that the peak of COVID-19 would occur during April/May and would slowly return to normal in a v-shaped or hockey-stick shaped recovery. However, data show COVID-19 did not peak solely in the April/May time frame ...